Comparison of Effect of Lavandula officinalis and Venlafaxine in Treating Depression: A Double Blind Clinical Trial

Comparison of Effect of Lavandula officinalis and Venlafaxine in Treating Depression: A Double Blind Clinical Trial

Introduction: Major depressive disorder is a chronic disease which may be associated with other mental illnesses. Lavandula officinalis and venlafaxine, herbal and chemical drugs respectively, are used to treat depression. Despite pharmacotherapy, major depressive disorder has a complicated pat...

Full description

Bibliographic Details
Main Authors:	Masoud Nikfarjam, Reza Rakhshan, Hourivash Ghaderi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-07-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	antidepressant depressive disorder medicinal plant
Online Access:	https://jcdr.net/articles/PDF/10233/20657_CE[Ra1]_F(SS)_PF1(RU_VT_RB)_PFA(P_RB).pdf

Similar Items

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-03-01)

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-04-01)

Antidepressants are an Important Part of Treating Depression
by: Jitender eSareen, et al.
Published: (2012-07-01)

Comparison of Lavandula officinalis tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized pilot study
by: M Khani, et al.
Published: (2002-05-01)

A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression
by: Mostafa Araj-Khodaei, et al.
Published: (2020-07-01)

Effect of Citalopram in Combination with Omega-3 on Depression in Post-menopausal Women: A Triple Blind Randomized Controlled Trial
by: Seyedeh Zahra Masoumi, et al.
Published: (2016-10-01)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
by: Víctor Pérez, et al.
Published: (2017-07-01)

Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials
by: D. S. Danilov
Published: (2017-03-01)

Antidepressants versus interpersonal psychotherapy in treating depression in HIV-positive patients.
by: M Y H Moosa, et al.
Published: (2012-05-01)

Pattern of outcome with sertraline, imipramine, and des-venlafaxine in unipolar nonpsychotic depression
by: Abhishek Kapoor, et al.
Published: (2015-01-01)

Identification de biomarqueurs génétiques de réponse à la venlafaxine dans une cohorte de patients déprimés
by: Taranu, Adela
Published: (2017)

Acupuncture versus Western medicine drugs (antidepressant) to treat depression
by: Anggaraeni Krta, et al.
Published: (2019-01-01)

Use of antidepressants among depressed treated with internet-based Cognitive Behaviour Therapy (CBT)
by: Dominique Hange, et al.
Published: (2013-11-01)

Use of antidepressants among depressed treated with internet-based Cognitive Behaviour Therapy (CBT)
by: Dominique Hange, et al.
Published: (2013-11-01)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
by: Durgam S, et al.
Published: (2016-12-01)

Transcranial direct current stimulation in treatment resistant depression: A randomized double-blind, placebo-controlled study
by: U. Palm, et al.
Published: (2012-07-01)

DEPRESSION IN PRIMARY CARE. PART 2: MANAGEMENT
by: XV Pereira, et al.
Published: (2007-01-01)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
by: Aldosary, F., et al.
Published: (2022)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)

A Study of Antidepressant Prescription in Major Depressive Disorders in the Out-Patient Psychiatric Department of Siriraj Hospital
by: Somporn Wipisamakul, et al.
Published: (2005-08-01)

Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
by: J.G. Santos Junior, et al.
Published: (2002-04-01)

MicroRNAs and depression
by: Sophie Mouillet-Richard, et al.
Published: (2012-05-01)

Longitudinal monitoring of the course of depressive disorders: Careful monitoring of the course of depressive episode
by: Kostić Milutin, et al.
Published: (2020-01-01)

Diagnosis, phenomenology and treatment of poststroke depression
by: Starkstein Sergio E, et al.
Published: (2002-01-01)

Depression and obesity: What is the right choice of medication?
by: Latas Milan
Published: (2017-01-01)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
by: Zuilhof Z, et al.
Published: (2018-11-01)

Pathogenesis, clinical features, and treatments of depression in Parkinson's disease
by: I. V. Milyukhina
Published: (2019-06-01)

THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY
by: L. V. Lipatova, et al.
Published: (2016-12-01)

Taking the perspective that a depressive state reflects inflammation: implications for the use of antidepressants
by: Jill Leslie Littrell
Published: (2012-08-01)

Chronic pain and depression
by: Davide Cristina
Published: (2021-06-01)

Hyponatremia misdiagnosed as depression
by: Neena S Sawant, et al.
Published: (2019-01-01)

Immunological changes in depression
by: Sunil Goyal, et al.
Published: (2017-01-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
by: Yu. V. Solomatin, et al.
Published: (2016-12-01)

Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment
by: Peter Hutka, et al.
Published: (2021-01-01)

Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats
by: Batool Rahmati, et al.
Published: (2017-01-01)

Depression and coronary heart disease
by: Blanka Kores-Plesničar, et al.
Published: (2007-05-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Preliminary Clinical Investigation of Combinatorial Pharmacogenomic Testing for the Optimized Treatment of Depression: A Randomized Single-Blind Study
by: Xiaoxiao Shan, et al.
Published: (2019-09-01)

Modern approaches to the pharmacotherapy of postpartum depression
by: A. V. Ovchinnikov, et al.
Published: (2020-08-01)

Depression and heart failure: an intricate relationship
by: Gaetano Aloisi, et al.
Published: (2019-09-01)